These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6229495)

  • 41. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    Owens T; Crispe IN
    J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
    Thompson K
    J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U; Shearer GM
    J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
    Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
    Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms.
    Watson GA; Fu YX; Lopez DM
    J Leukoc Biol; 1991 Feb; 49(2):126-38. PubMed ID: 1991996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry.
    MacDonald HR; Lees RK; Sordat B; Zaech P; Maryanski JL; Bron C
    J Immunol; 1981 Mar; 126(3):865-70. PubMed ID: 6970223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
    Leshem B; Kedar E
    J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Origin of autoreactive T helper cells. I. Characterization of Thy-1+, Lyt-, L3T4- precursors in the spleen of normal mice.
    de Talance A; Regnier D; Spinella S; Morisset J; Seman M
    J Immunol; 1986 Aug; 137(4):1101-8. PubMed ID: 2426351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of complement receptor-bearing cells in the spleens of tumor-bearing mice.
    Epstein RS; Lopez DM; Sigel MM; Ross GD
    J Immunol; 1978 Oct; 121(4):1524-7. PubMed ID: 308966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
    Van Ewijk W
    Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Busulfan and chloramphenicol induced T cell lymphoma: cell surface characteristics and functional properties.
    Bhoopalam N; Price K; Norgello H; Barone-Varelas J; Fried W
    Clin Exp Immunol; 1986 Jun; 64(3):646-55. PubMed ID: 2947760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody against a cryptic carbohydrate antigen of murine and human lymphocytes. I. Antigen expression in non-cryptic or unsubstituted form on certain murine lymphomas, on a spontaneous murine mammary carcinoma, and on several human adenocarcinomas.
    Longenecker BM; Rahman AF; Leigh JB; Purser RA; Greenberg AH; Willans DJ; Keller O; Petrik PK; Thay TY; Suresh MR
    Int J Cancer; 1984 Jan; 33(1):123-9. PubMed ID: 6198295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
    Lake JP; Kapp JA; Pierce CW
    J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND; Kreider JW; Horetsky RL
    Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.